Berlin: Pfizer-Biontech's coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 per cent, according to real world evidence published Thursday by pharma companies. Using data from January 17 to March 6 from Israel's national vaccination campaign, Pfizer-Biontech found that prevention against asymptomatic disease also reached 94 per cent. An earlier real world study had showed effectiveness at preventing symptomatic disease at 94 per cent and asymptomatic illness at 92 per cent.
Hence then, the article about pfizer jab 97 effective against symptomatic covid study was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Pfizer jab 97% effective against symptomatic COVID: study )